Patient
SITE007-0021
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2025-09-11
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-12-20 (study day 268); relationship: NOT RELATED
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-10-28 (study day 215); relationship: NOT RELATED
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-09 (study day 104); relationship: NOT RELATED
Grade 2 Hepatitis — outcome: RECOVERED/RESOLVED; onset 2022-07-06 (study day 101); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.